Huizenga Theodore Alan

Avg. Two Year Performance

No purchase track record
12% Avg. Sale Return
6% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return3%3%4%12%12%
Sale Success Rate5 of 155 of 155 of 155 of 156 of 15
Drugs » Biotechnology

SVP, Chief Accounting Officer:

Holdings: 41.38K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--